Stockreport

Insider Spends US$132k Buying More Shares In Aprea Therapeutics [Yahoo! Finance]

Aprea Therapeutics, Inc.  (APRE) 
PDF NASDAQ:APRE ) shareholders may wish to note that the Independent Director, Marc Duey, recently bought US$132k worth of stock, paying US$4.39 for each share. That's a ver [Read more]